Medicine and Dentistry
Bladder Cancer
100%
Neoadjuvant Chemotherapy
100%
Cisplatin
100%
Specimen
38%
Mesenchymal-Epithelial Transition
30%
Transurethral Resection
30%
Patient
23%
Programmed Cell Death
23%
Biological Marker
15%
Cytoskeleton
15%
Cystectomy
15%
Bladder
15%
Transitional Cell Carcinoma
15%
Cofilin
15%
Phosphorylation
15%
Actin
15%
Diseases
7%
Therapeutic Procedure
7%
Chemotherapy
7%
Marker
7%
Mortality Rate
7%
Neoplasm
7%
Mortality
7%
Primary Tumor
7%
Tissue Microarray
7%
Clinical Stage
7%
Treatment Response
7%
Lymph Node Metastasis
7%
Nerve Cell Adhesion Molecule
7%
Cancer Specific Survival
7%
Surgery
7%
Survival
7%
Therapeutics
7%
Biochemistry, Genetics and Molecular Biology
Mesenchymal-Epithelial Transition
100%
Cisplatin
100%
Phosphorylation
50%
Cytoskeleton
50%
Apoptosis
50%
Actin
50%
Cofilin
50%
Mortality
25%
Mortality Rate
25%
Survival
25%
Apoptosis Rate
25%
Tissue Microarray
25%
Neural Cell Adhesion Molecule
25%
Cancer Specific Survival
25%
Immunology and Microbiology
Epithelial Mesenchymal Transition
100%
Cytoskeleton
50%
Phosphorylation
50%
Apoptosis
50%
Actin
50%
Mortality Rate
25%
Mortality
25%
Survival
25%
Apoptosis Rate
25%
Cancer Specific Survival
25%
Lymph Node
25%
Neural Cell Adhesion Molecule
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Chemotherapy
100%
Bladder Cancer
100%
Apoptosis
21%
Biological Marker
14%
Cofilin
14%
Actin
14%
Transitional Cell Carcinoma
14%
Mortality Rate
7%
Survival
7%
Mortality
7%
Cancer Specific Survival
7%
Lymph Node Metastasis
7%
Nerve Cell Adhesion Molecule
7%
Disease
7%
Neoplasm
7%
Primary Tumor
7%